Form S-3ASR - Automatic shelf registration statement of securities of well-known seasoned issuers:
SEC Accession No. 0001104659-25-014191
Filing Date
2025-02-14
Accepted
2025-02-14 16:31:51
Documents
19
Effectiveness Date
2025-02-14

Document Format Files

Seq Description Document Type Size
1 S-3ASR tm255723-1_s3asr.htm S-3ASR 203575
2 EXHIBIT 5.1 tm255723d2_ex5-1.htm EX-5.1 15251
3 EXHIBIT 23.1 tm255723d2_ex23-1.htm EX-23.1 3117
4 EXHIBIT 25.1 tm255723d2_ex25-1.htm EX-25.1 109931
5 FILING FEE IXBRL tm255723d1_ex-filingfees.htm   iXBRL EX-FILING FEES 16652
6 GRAPHIC tm255723d2_ex5-1img001.jpg GRAPHIC 3679
7 GRAPHIC lg_abbvie-4c.jpg GRAPHIC 20693
8 GRAPHIC tm255723d2_ex25-1img002.jpg GRAPHIC 76801
  Complete submission text file 0001104659-25-014191.txt   608280

Data Files

Seq Description Document Type Size
21 EXTRACTED XBRL INSTANCE DOCUMENT tm255723d1_ex-filingfees_htm.xml XML 3713
Mailing Address 1 NORTH WAUKEGAN ROAD NORTH CHICAGO IL 60064
Business Address 1 NORTH WAUKEGAN ROAD NORTH CHICAGO IL 60064 (847) 932-7900
AbbVie Inc. (Filer) CIK: 0001551152 (see all company filings)

EIN.: 320375147 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3ASR | Act: 33 | File No.: 333-284980 | Film No.: 25629738
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)